Weight-loss and diabetes drug semaglutide shows promise in fighting metabolic dysfunction-associated steatohepatitis and liver fibrosis. The once-weekly shot, marketed as Ozempic, Wegovy and Rybelsus, could be a breakthrough treatment for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive form of fatty liver disease. So what’s the deal with semaglutide and MASH? Published in April 2025 in the […]

The post Semaglutide: A new tool to treat MASH appeared first on Medical News Bulletin.

Non-alcoholic steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD) are both liver conditions that are best given immediate attention. NAFLD is the commoner and the milder of the two. When NAFLD graduates into NASH, it can become life-threatening, resulting in liver cancer or scarring. Early detection makes for effective treatment and recovery. This liver condition […]

The post What Are The Early Symptoms of Non-alcoholic Steatohepatitis and Fatty Liver Disease, And What Are The Available Test Methods? appeared first on Medical News Bulletin.

In a recent study published in JAMA, researchers determined whether reducing added sugars will improve fatty liver disease in kids. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in children. It is associated with an increased risk of type 2 diabetes, end-stage liver disease, liver cancer, and cardio-vascular disease. Added sugar in the […]

The post Does reducing added sugars improve fatty liver disease in kids? appeared first on Medical News Bulletin.

In a study, researchers examined the link between a high-fat diet in mouse models and the progression towards liver damage. A common form of liver disease is non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease is so common, that it seems that in a couple of years, it may eventually serve as a good predictor […]

The post How is a high-fat diet related to liver damage? appeared first on Medical News Bulletin.

A team of International researchers investigated the role of PRO-C3 as a biomarker to predict the absence or presence of liver damage in patients with non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease, also known as fatty liver, occurs when more than 5% of the liver is made up of fatty tissue and affects people […]

The post Researchers develop algorithm to identify liver damage in fatty liver disease appeared first on Medical News Bulletin.

A recent study published in Nutrition & Metabolism summarizes the current understanding of the role vitamin D plays in liver disorders. Vitamin D is a fat-soluble vitamin that plays an important role in calcium homeostasis, metabolism, and immune responses. It is an essential nutrient that confers benefits to the heart and regulates insulin secretion, anti-microbial […]

The post The Role of Vitamin D in Liver Disorders appeared first on Medical News Bulletin.

It has been shown that excessive intake of fat, cholesterol, and carbohydrates in the diet is correlated with the development of fatty liver disease. Scientists recently conducted a study to determine how each individual diet component affects the progression and initiation of fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) is a rising liver disease, […]

The post Researchers solve mystery behind fatty liver disease appeared first on Medical News Bulletin.

Researchers investigated whether modest alcohol consumption can reduce liver fibrosis and cell damage in patients with non-alcoholic fatty liver disease. The liver is a large organ located in the right upper abdomen just under the rib cage. It has many important functions including filtering the nutrients in blood coming from the digestive tract, storing and […]

The post Can Modest Alcohol Intake Suppress Liver Fibrosis in Fatty Liver Disease? appeared first on Medical News Bulletin.